Biocon reports PAT of Rs 107 crore in H12007-08, Revenue Rs 553 cr

Thursday, October 18, 2007, 15:26 [IST]

Bangalore, Oct 18: Reporting a 27 per cent growth in net profit, biotech major Biocon Limited today annmounced a revenue of Rs 553 crore and a net profit of Rs 107 crore for the first half of the current fiscal.

Consolidated Revenues grew by 19 per cent over the same period in the previous year. Research Services (Syngene) continued to deliver a robust dollar denominated growth of 60 per cent and an impressive 43 per cent based on Rupee realisation. Profit was restrained by rupee appreciation, the Company said in a release..

Biopharmaceuticals and branded formulations showed strong performance. Insulin was a significant contributor.

Technology and licensing revenues continued to contribute to H-1 financials.

The Company said its R and D expenditure increased to Rs 32 crore from Rs 19 crore in the previous year.

UNI

Topics: biocon, bangalore, rupee, dollar, technology

Other articles published on October 18, 2007

Biotechnology major Biocon forays into nephrology space

Friday, March 9, 2007,12:21 [IST]

Bangalore, Mar 09: Biotechnology major Biocon on Thursday forayed into the nephrology space with the launch of a portfolio of five renal therapy products for the domestic and global markets, which it said was cheaper compared to MNC drug prices. The new immunosuppressants for renal therapy are at least 35-40 per cent cheaper than the MNC drug prices in the similar product category, the company's Marketing Head Rakesh Bamzai said.The Bangalore-headquartered company's Chairman and Managing Director, Kiran Mazumdar-Shaw said.....

Leading Asia-Pacific Biotech meet on June 7

Monday, June 4, 2007,17:15 [IST]

Bangalore, Jun 4: Growing in size and strength every year, the premier Biotech event of the country, Bangalore Bio 2007 will kick off here on June seven with over 150 companies from 12 countries participating in the much sought after event of the Asia Pacific region.The three day show to be inaugurated by Finance Miniter P Chidambaram will showcase globally the increasing biotech strength of the country. As many as eleven states would have presence in the event for which.....

Limitless Updates

Business News

News Archives

Biocon eyes acquisition by March '08

Monday, December 3, 2007,14:06 [IST]

New Delhi, Dec 3: Biocon Ltd, country's fully integrated healthcare company, plans to acquire a firm by the end of the current financial year to boost its business in overseas markets. ''We are looking at US, Europe and some of the emerging markets,'' company's Chairman Kiran Mazumdar-Shaw told reporters at India Economic Summit jointly organised by the World Economic Forum and CII here today. The Bangalore-based firm has six pharmaceutical products in its discovery pipeline, and that Biocon plans to launch.....